The Goldman Sachs Group Cuts Clorox (NYSE:CLX) Price Target to $110.00

Clorox (NYSE:CLX) had its price objective cut by The Goldman Sachs Group from $115.00 to $110.00 in a research note released on Wednesday,MarketScreener reports. They currently have a sell rating on the stock.

CLX has been the subject of several other reports. TD Cowen lowered their price objective on shares of Clorox from $120.00 to $117.00 and set a “hold” rating for the company in a research report on Wednesday. Wells Fargo & Company lowered their price objective on shares of Clorox from $130.00 to $125.00 and set an “equal weight” rating for the company in a research report on Thursday, September 25th. Morgan Stanley lowered their price objective on shares of Clorox from $150.00 to $137.00 and set an “equal weight” rating for the company in a research report on Friday, August 1st. Zacks Research upgraded shares of Clorox from a “strong sell” rating to a “hold” rating in a research report on Monday, September 29th. Finally, JPMorgan Chase & Co. boosted their price objective on shares of Clorox from $133.00 to $135.00 and gave the company a “neutral” rating in a research report on Monday, September 8th. One equities research analyst has rated the stock with a Buy rating, ten have given a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Reduce” and an average price target of $134.08.

Clorox Trading Up 0.9%

Shares of CLX stock opened at $123.30 on Wednesday. The company has a current ratio of 0.84, a quick ratio of 0.57 and a debt-to-equity ratio of 5.15. The stock has a market cap of $15.08 billion, a P/E ratio of 18.91, a price-to-earnings-growth ratio of 0.98 and a beta of 0.52. The stock has a 50 day simple moving average of $122.81 and a 200 day simple moving average of $129.64. Clorox has a 1 year low of $116.53 and a 1 year high of $171.37.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Thursday, July 31st. The company reported $2.87 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.24 by $0.63. The business had revenue of $1.99 billion during the quarter, compared to analysts’ expectations of $1.94 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The firm’s revenue for the quarter was up 4.5% compared to the same quarter last year. During the same period in the previous year, the company posted $1.82 earnings per share. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. On average, research analysts predict that Clorox will post 7.15 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, November 6th. Investors of record on Wednesday, October 22nd will be paid a $1.24 dividend. The ex-dividend date of this dividend is Wednesday, October 22nd. This represents a $4.96 annualized dividend and a dividend yield of 4.0%. Clorox’s payout ratio is currently 76.07%.

Insider Buying and Selling at Clorox

In related news, COO Eric H. Reynolds sold 15,041 shares of the business’s stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $123.78, for a total value of $1,861,774.98. Following the sale, the chief operating officer owned 54,221 shares of the company’s stock, valued at $6,711,475.38. The trade was a 21.72% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 0.57% of the stock is currently owned by corporate insiders.

Institutional Trading of Clorox

A number of institutional investors have recently bought and sold shares of the company. Vanguard Group Inc. boosted its position in Clorox by 1.7% during the second quarter. Vanguard Group Inc. now owns 15,845,496 shares of the company’s stock valued at $1,902,569,000 after acquiring an additional 272,420 shares during the last quarter. Invesco Ltd. boosted its position in Clorox by 138.3% during the second quarter. Invesco Ltd. now owns 3,245,175 shares of the company’s stock valued at $389,648,000 after acquiring an additional 1,883,465 shares during the last quarter. Norges Bank bought a new stake in Clorox during the second quarter valued at $190,429,000. Northern Trust Corp boosted its position in Clorox by 2.3% during the first quarter. Northern Trust Corp now owns 1,528,920 shares of the company’s stock valued at $225,133,000 after acquiring an additional 34,655 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership boosted its position in Clorox by 218.4% during the second quarter. Arrowstreet Capital Limited Partnership now owns 1,249,127 shares of the company’s stock valued at $149,983,000 after acquiring an additional 856,873 shares during the last quarter. Institutional investors own 78.53% of the company’s stock.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.